Cadence Pharmaceuticals, Inc. (CADX) Posts Slightly Wide Loss of 28c Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts CADX Hot Sheet
Price: $13.98 --0%
Financial Fact:
Product revenue, net: 33.29M
Today's EPS Names:
NRIX, VFS, GLDG, More
Financial Fact:
Product revenue, net: 33.29M
Today's EPS Names:
NRIX, VFS, GLDG, More
Join SI Premium – FREE
Cadence Pharmaceuticals, Inc. (NASDAQ: CADX) reported Q4 EPS of ($0.28), $0.01 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $5.9 million versus the consensus estimate of $6.88 million.
For earnings history and earnings-related data on Cadence Pharmaceuticals, Inc. (CADX) click here.
For earnings history and earnings-related data on Cadence Pharmaceuticals, Inc. (CADX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Top AI Semiconductor Stocks According to Stifel Analysis
- HIMS jumps 7% on peptide tailwind but Citi sees 17% downside from here
- Amrize Ltd (AMRZ) PT Lowered to $40 at DA Davidson as FY26 Guidance 'at Risk'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
